Drugs in the Pipeline Baricitinib Alone Authorized for COVID-19 Under Revised EUA Publish Date July 29, 2021 The update was based on data from the COV-BARRIER study.
News Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy Publish Date December 14, 2021 Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.